Skip to main content
Terug
Watch Compare

Minerva Neurosciences, Inc.

Datakwaliteit: 83%
NERV
NASDAQ Manufacturing Chemicals
€ 5,51
▼ € 0,51 (-8,47%)
Marktkapitalisatie: 239,96 M
Prijs
€ 5,55
Marktkapitalisatie
239,96 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Earnings declined -20492,68% over the past year
Negative free cash flow of -13,51 M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)-20492,68%
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
N/A
ROIC-44,76%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
N/A
Current Ratio4,87
Interest CoverageN/A

Waardering

PE (TTM|NTM)
-0,82 | -11,48
Boven sectorgemiddelde (-1,49)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1385 peers)
Metriek Aandeel Sector Mediaan
P/E -0,8 -1,5
P/B — 1,6
ROE % — -54,0
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Koersdoel Analisten

2 analisten
Hold
Huidig
€ 5,51
+31.6%
Koersdoel
€ 7,25
€ 7,00
€ 7,25
€ 7,50
Vooruitzicht
Forward K/W -11,48
Forward WPA -€ 0,48
Omzet Sch. 0,0

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 -€ 0,48
-€ 0,48 – -€ 0,48
 0,0 1
FY2026 -€ 0,60
-€ 0,60 – -€ 0,60
 0,0 1

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q42025 -€ 0,11 -€ 0,64 -481,8%
Q32025 N/A -€ 0,36 —
Q22025 -€ 0,90 -€ 0,43 +52,2%
Q12025 -€ 1,07 -€ 0,50 +53,3%

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) -20492,68% Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -293,42 M
ROE N/A ROA -1002,96%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -13,51 M
ROIC -44,76% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 4,87
Interest Coverage N/A Asset Turnover N/A
Working Capital 10,35 M Tangible Book Value -49,45 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,82 Forward P/E -11,48
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -5,63%
Market Cap 239,96 M Enterprise Value 227,67 M
Per Share
EPS (Diluted TTM) -34,67 Revenue / Share N/A
FCF / Share -0,31 OCF / Share -0,31
EPS CAGR (1Y) -18347,37% EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 4,60%
SBC-Adj. FCF -14,69 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — 0,0 0,0 0,0 41,18 M
Net Income -293,42 M 1,44 M -30,01 M -32,11 M -49,91 M
EPS (Diluted) -34,67 0,19 -4,61 -6,01 -1,17
Gross Profit — — — — —
Operating Income -15,10 M -21,85 M -23,12 M -25,23 M -45,37 M
EBITDA — — — — —
R&D Expenses 5,76 M 11,90 M 12,71 M 14,65 M 32,04 M
SG&A Expenses — — — — —
D&A 5.442,0 5.442,0 5.442,0 — 16.011,0
Interest Expense — — — — —
Income Tax — — — -1,80 M -1,80 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 97,97 M 37,14 M 56,90 M 55,09 M 77,12 M
Total Liabilities 233,76 M 62,84 M 85,36 M 75,11 M 69,15 M
Shareholders' Equity -140,75 M -25,69 M -28,46 M -20,02 M 7,98 M
Total Debt — — — — —
Cash & Equivalents 82,30 M 21,36 M 40,91 M 36,09 M 60,76 M
Current Assets 83,10 M 22,27 M 42,00 M 40,16 M 62,20 M
Current Liabilities 2,29 M 2,84 M 3,34 M 1,38 M 2,82 M